Spots Global Cancer Trial Database for imatinib resistant or intolerant
Every month we try and update this database with for imatinib resistant or intolerant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor | NCT00793871 | Gastrointestina... | Sunitinib Malat... | 18 Years - | Pfizer | |
Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | NCT01073644 | Metastatic Rena... | Sunitinib malat... | 18 Years - 75 Years | Pfizer | |
Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | NCT01073644 | Metastatic Rena... | Sunitinib malat... | 18 Years - 75 Years | Pfizer |